Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8884181rdf:typepubmed:Citationlld:pubmed
pubmed-article:8884181lifeskim:mentionsumls-concept:C0026844lld:lifeskim
pubmed-article:8884181lifeskim:mentionsumls-concept:C1135918lld:lifeskim
pubmed-article:8884181lifeskim:mentionsumls-concept:C0016895lld:lifeskim
pubmed-article:8884181lifeskim:mentionsumls-concept:C0018270lld:lifeskim
pubmed-article:8884181lifeskim:mentionsumls-concept:C1710082lld:lifeskim
pubmed-article:8884181lifeskim:mentionsumls-concept:C1704259lld:lifeskim
pubmed-article:8884181lifeskim:mentionsumls-concept:C1160185lld:lifeskim
pubmed-article:8884181lifeskim:mentionsumls-concept:C1705987lld:lifeskim
pubmed-article:8884181lifeskim:mentionsumls-concept:C0441712lld:lifeskim
pubmed-article:8884181pubmed:issue1lld:pubmed
pubmed-article:8884181pubmed:dateCreated1997-2-21lld:pubmed
pubmed-article:8884181pubmed:abstractTextGangliosides appear to regulate proliferation of different cell types. In the present study, we investigated the effects of gangliosides GM1, GM2 and GM3 on platelet-derived growth factor (PDGF)-induced vascular smooth muscle cell (VSMC) growth. In addition, we examined the effects of gangliosides on the PDGF-BB-dependent signalling transduction pathway in rat aortic VSMC. GM2 and GM1 inhibit the PDGF-BB-dependent receptor tyrosine autophosphorylation, stimulation of the PLC-gamma 1, increase of inositol-1,4,5-trisphosphate (InsP3), elevation in cytosolic free Ca2+ ([Ca2+]i), expression of the immediate early growth response gene c-fos and cell proliferation with the following rank order of potency GM2 > GM1. Although GM3 did not influence the PDGF-BB-dependent receptor autophosphorylation and PLC-gamma 1 activation, it effectively inhibited the PDGF-BB-dependent InsP3 formation, [Ca2+]i and cell growth. Binding studies with 125I-PDGF-BB on VSMC in the presence and absence of 10 to 50 microM of each ganglioside revealed that GM1 and GM2 effectively inhibited the specific binding of PDGF-BB with an IC50 value of 20 microM for GM2 and 30 microM for GM1. GM3 had no significant effect on the specific 125I-PDGF-BB binding. These observations suggest that GM1 and GM2 may interact with PDGF-BB or its receptor resulting in a prevention of its binding. GM3 was able to suppress the PDGF-BB-dependent increase of InsP3 and [Ca2+]i downstream of the PDGF-BB-dependent receptor autophosphorylation and PLC-gamma 1 activity.lld:pubmed
pubmed-article:8884181pubmed:languageenglld:pubmed
pubmed-article:8884181pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8884181pubmed:citationSubsetIMlld:pubmed
pubmed-article:8884181pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8884181pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8884181pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8884181pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8884181pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8884181pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8884181pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8884181pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8884181pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8884181pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8884181pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8884181pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8884181pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8884181pubmed:statusMEDLINElld:pubmed
pubmed-article:8884181pubmed:monthSeplld:pubmed
pubmed-article:8884181pubmed:issn0171-9335lld:pubmed
pubmed-article:8884181pubmed:authorpubmed-author:VetterHHlld:pubmed
pubmed-article:8884181pubmed:authorpubmed-author:KrausRRlld:pubmed
pubmed-article:8884181pubmed:authorpubmed-author:HoppeJJlld:pubmed
pubmed-article:8884181pubmed:authorpubmed-author:DASG DGDlld:pubmed
pubmed-article:8884181pubmed:authorpubmed-author:SchulteKKlld:pubmed
pubmed-article:8884181pubmed:authorpubmed-author:SachinidisAAlld:pubmed
pubmed-article:8884181pubmed:authorpubmed-author:SeulCClld:pubmed
pubmed-article:8884181pubmed:authorpubmed-author:Meyer zu...lld:pubmed
pubmed-article:8884181pubmed:issnTypePrintlld:pubmed
pubmed-article:8884181pubmed:volume71lld:pubmed
pubmed-article:8884181pubmed:ownerNLMlld:pubmed
pubmed-article:8884181pubmed:authorsCompleteYlld:pubmed
pubmed-article:8884181pubmed:pagination79-88lld:pubmed
pubmed-article:8884181pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:8884181pubmed:meshHeadingpubmed-meshheading:8884181-...lld:pubmed
pubmed-article:8884181pubmed:meshHeadingpubmed-meshheading:8884181-...lld:pubmed
pubmed-article:8884181pubmed:meshHeadingpubmed-meshheading:8884181-...lld:pubmed
pubmed-article:8884181pubmed:meshHeadingpubmed-meshheading:8884181-...lld:pubmed
pubmed-article:8884181pubmed:meshHeadingpubmed-meshheading:8884181-...lld:pubmed
pubmed-article:8884181pubmed:meshHeadingpubmed-meshheading:8884181-...lld:pubmed
pubmed-article:8884181pubmed:meshHeadingpubmed-meshheading:8884181-...lld:pubmed
pubmed-article:8884181pubmed:meshHeadingpubmed-meshheading:8884181-...lld:pubmed
pubmed-article:8884181pubmed:meshHeadingpubmed-meshheading:8884181-...lld:pubmed
pubmed-article:8884181pubmed:meshHeadingpubmed-meshheading:8884181-...lld:pubmed
pubmed-article:8884181pubmed:meshHeadingpubmed-meshheading:8884181-...lld:pubmed
pubmed-article:8884181pubmed:meshHeadingpubmed-meshheading:8884181-...lld:pubmed
pubmed-article:8884181pubmed:meshHeadingpubmed-meshheading:8884181-...lld:pubmed
pubmed-article:8884181pubmed:meshHeadingpubmed-meshheading:8884181-...lld:pubmed
pubmed-article:8884181pubmed:meshHeadingpubmed-meshheading:8884181-...lld:pubmed
pubmed-article:8884181pubmed:meshHeadingpubmed-meshheading:8884181-...lld:pubmed
pubmed-article:8884181pubmed:meshHeadingpubmed-meshheading:8884181-...lld:pubmed
pubmed-article:8884181pubmed:meshHeadingpubmed-meshheading:8884181-...lld:pubmed
pubmed-article:8884181pubmed:meshHeadingpubmed-meshheading:8884181-...lld:pubmed
pubmed-article:8884181pubmed:meshHeadingpubmed-meshheading:8884181-...lld:pubmed
pubmed-article:8884181pubmed:meshHeadingpubmed-meshheading:8884181-...lld:pubmed
pubmed-article:8884181pubmed:meshHeadingpubmed-meshheading:8884181-...lld:pubmed
pubmed-article:8884181pubmed:year1996lld:pubmed
pubmed-article:8884181pubmed:articleTitleGangliosides GM1, GM2 and GM3 inhibit the platelet-derived growth factor-induced signalling transduction pathway in vascular smooth muscle cells by different mechanisms.lld:pubmed
pubmed-article:8884181pubmed:affiliationMedizinische Universitäts-Poliklinik, Bonn, Germany.lld:pubmed
pubmed-article:8884181pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8884181pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:8884181pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8884181lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8884181lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8884181lld:pubmed